Choosing a Peptide Label: Fluorophore, Biotin or Radioiodine

A labeled peptide is just an ordinary sequence carrying a reporter group, and which reporter you pick follows from the detection instrument already sitting in the laboratory — fluorescence for imaging and plate-based binding, a biotin tag for capture and enzymatic amplification, radioiodine where receptor and immunoassay work demands maximum sensitivity. Every label brings extra mass, may bring a spacer, and can disturb binding if placed at the wrong terminus. Below: what each label family does, the mass each contributes so an identity result can be checked, the practical limits of each, and the decay arithmetic for radiolabeled material.

Fluorescent labels

Derivatives of fluorescein are the default choice because their excitation and emission wavelengths suit the filter sets in practically every plate reader, microscope and flow cytometer made in the past thirty years. Two applications account for most use:

• Binding assays by fluorescence polarisation. Free in solution, a small labeled peptide tumbles quickly and depolarises the emitted light; bound to a large receptor or antibody, it tumbles slowly and polarisation climbs. Since no separation step is needed, the homogeneous readout makes this the standard format for competition binding.
• FRET substrates for proteases. A donor fluorophore and a quencher sit on either side of a cleavage site: while the peptide is intact the emission is quenched, and once cleaved the fragments drift apart and signal appears. For the design to work, the enzyme must tolerate both label positions.

Two practical limits deserve to be stated outright. Because the fluorescent species is the phenolate, fluorescein emission drops sharply below pH 7, so a labeled peptide in acidic buffer may look absent when it is only dark. And fluorophores photobleach — keep stocks in darkness, limit exposure during reads, and run a same-day reference well.

Biotin labels

What biotin offers is the strength of the biotin–streptavidin interaction, whose dissociation constant near 10⁻¹⁴ M makes it effectively irreversible under ordinary assay conditions. That allows a peptide carrying biotin to be immobilised on a streptavidin-coated plate or bead and washed hard without loss, and it allows detection to be amplified through a streptavidin–enzyme conjugate — the very chemistry behind the sandwich formats in the range of assay kits.

Spacer design is the question that keeps coming up. Attach biotin directly to a short peptide and it sits so close to the sequence that streptavidin's pocket and the peptide's own binding partner compete sterically. Inserting an aminohexanoic acid (Ahx) spacer — 113.2 Da apiece, occasionally two — shifts biotin roughly 10–20 Å outward and normally restores both interactions. Poor capture by a biotinylated peptide should send you to the spacer first.

Worked example: confirming a labeled peptide by mass

1. Begin with the unlabeled mass. Semax, Met-Glu-His-Phe-Pro-Gly-Pro, is 813.93 Da.
2. Attach a 5-FAM label. Coupling carboxyfluorescein through an amide bond loses water and adds about 358 Da, giving 813.93 + 358 = ≈1,172 Da.
3. Or attach biotin with a single Ahx spacer: 813.93 + 226.3 + 113.2 = ≈1,153 Da.
4. Compare with the certificate. A mass equal to the unlabeled value means no coupling occurred, while a value 358 Da above expectation on a singly labeled peptide means a second label attached. How to read such results is covered in mass spectrometry and peptide identity.
5. Recalculate molarity. Since the label forms part of the molecule, molar calculations have to use the labeled mass — 1,172 against 814 is a 44% difference. See molecular weight, moles and molarity.

Radiolabels

Among labels available as routine, iodine-125 is still the most sensitive for peptide work. It goes onto tyrosine or histidine residues, is counted in a gamma counter without substrate or amplification, and reaches a theoretical ceiling of about 2,176 Ci/mmol for one iodine per molecule. That sensitivity explains why radioligand binding remains the reference method used to validate fluorescence-based binding assays, and why radioimmunoassay survives in work on neuropeptides, much of it catalogued under neuropeptide research, wherever an ELISA cannot reach the required detection limit.

Worked example: decay and the usable window

1. Half-life. Decay of I-125 proceeds with a half-life of 59.4 days.
2. At 30 days. Activity remaining = 0.5 to the power (30 ÷ 59.4) = 0.704, so a 100 µCi preparation now measures 70.4 µCi.
3. At 120 days. 0.5 to the power (120 ÷ 59.4) = 0.247 — roughly a quarter of what you started with, and in practice the end of most binding-assay windows.
4. What that means for design. Counting statistics worsen continuously, so recalculate specific activity at every use rather than relying on the shipping certificate, and design long time-course studies to accommodate the difference between first and last plate.

Radiolabeled peptides bring licensing, storage, monitoring and disposal duties that fluorescent and biotinylated alternatives avoid, and radiolysis gradually damages the peptide itself. For many binding questions the pragmatic answer is now a fluorescence-polarisation format; where the lowest detection limits are essential, radioiodine still has no equal.

Deciding where the label goes

• Put the label on whichever terminus is not the pharmacophore. Because so many signalling peptides bind through the C-terminus — amidated ones in particular — N-terminal labelling is the usual default; that reverses where the N-terminus matters, as with peptides recognised by aminopeptidase-sensitive receptors.
• Labelling a lysine ε-amine on a side chain is feasible, but unless exactly one lysine is present the result is a mixture, and mixtures behave erratically.
• Run the unlabeled parent in the same assay every time. A label that moves affinity by ten-fold has invalidated the experiment without saying so.
• Anticipate slightly looser purity specifications, since labelling adds a coupling step and a second purification, and labeled peptides are usually released a little below their unlabeled equivalents.

Storage and handling

• Keep material lyophilized, at −20 °C or colder, and dark — fluorophores are light-sensitive as solids no less than in solution.
• Spare fluorescent stocks from repeated warming by aliquoting at first reconstitution.
• Read fluorescein-labeled peptides at pH 7 or above, and record buffer pH next to the signal.
• Work with radiolabeled material only under the applicable licence, with survey monitoring and dedicated waste routes in place.

Our labeled range and how the catalogue is organised are set out under labeled peptides: what they are and how to choose, browsable via labeled peptides in the research catalog.